Childhood leukemia: Central nervous system abnormalities during and after treatment

American Journal of Neuroradiology

Volumn 17, Issue 2, 1996, Pages 295-310

  Chen, Cheng Yu ^a,b   Zimmerman, Robert A ^a   Faro, Scott ^a   Bilaniuk, Larissa T ^a   Chou, Ting Ywan ^b   Molloy, Patricia T ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Children, diseases; Leukemia

Indexed keywords

AMPHOTERICIN; ANTINEOPLASTIC AGENT; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIDOL; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; RETINOIC ACID; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN LEUKEMIA; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROVASCULAR DISEASE; CHILD; CHILDHOOD LEUKEMIA; CHLOROMA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; FEMALE; HUMAN; HUMAN TISSUE; INFANT; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIC MENINGITIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEUROLOGICAL COMPLICATION; NEUROPATHOLOGY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; BRAIN DAMAGE, CHRONIC; CENTRAL NERVOUS SYSTEM DISEASES; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LEUKEMIA; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030050403     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Cancer Facts and Figures. Atlanta, Ga: American Cancer Society, 1987
2. Evans AE, Gilbert ES, Zandstra R. The increasing incidence of central nervous leukemia in children. Cancer 1970; 26:404-409
3. Niemeyer CM, Kitchcock-Bryan S, Sallan SE. Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia. Semin Oncol 1985; 12:122-130
4. Walker RW. Neurologic complications of leukemia. Neurol Clin 1991; 9:989-999
5. Feinberg WM, Swenson MR. Cerebrovascular complications of L-asparaginase therapy. Neurology 1988; 38:127-133
6. Flament-Durand J, Ketekbant-Balasse P, Maurus R, Regnier R, Spehl M. Intracerebral calcifications appearing during the course of acute lymphocytic leukemia treated with methotrexate and X rays. Cancer 1975; 35:319-325
7. Rubinstein LJ, Herman MM, Long TF, Wilbur JR. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 1975; 35: 291-305
8. Biti GP, Magrini SM, Vilan N, et al. Brain damage after treatment for acute lymphoblastic leukemia. Acta Oncol 1989; 28:253-256
9. Yim YS, Mahoney DH, Oshman DC. Hemiparesis and ischemic changes of the white matter after intrathecal therapy for children with acute lymphocytic leukemia. Cancer 1991; 67:2058-2061
10. Priest JR, Ramsay NKC, Steinherz PG, et al. A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia Pediatrics 1982; 100:984-989
11. Ball WS, Prenger EC, Ballard ET. Neurotoxicity of radio/chemotherapy in children: pathologic and MR correlation. AJNR Am J Neuroradiol 1992; 13:761-776
12. Robertson KA. Pediatric bone marrow transplantation. Curr Opin Pediatr 1993; 5:103-109
13. Mulhem RK, Ochs J, Fairclough D, et al. Psychoeducational status following central nervous system relapse: a retrospective analysis of 40 children treated for acute lymphoblastic leukemia. J Clin Oncol 1987; 5:933-940
14. Asato RA, Akiyama Y, Masatoshi I, et al. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 1992; 70:1997-2004
15. Tsuruda JS, Kortman KE, Bradley WG, Wheeler DC, Dalsem WV, Bradley TP. Radiation effects on cerebral white matter: MR evaluation. AJNR Am J Neuroradiol 1987; 8:431-437
16. Packer RJ, Zimmerman RA, Bilaniuk LT. Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer 1986; 58:635-640
17. Allen JC, Deck MDF, Howieson J, Brown M. CT scans of longterm survivors of various childhood malignancies. Med Pediatr Oncol 1981; 9:109-117
18. Meadows AT, Kreimas NL, Belasco JB. The medical cost of cure: sequelae in survivors of childhood cancer. In: Sullivan MP, van Eys J, eds. Status of the Curability of Childhood Cancer. New York, NY: Raven Press, 1980: 263-276
19. Ebner F, Ranner G, Slave I, et al. MR findings in methotrexate-induced CNS abnormalities. AJNR Am J Neuroradiol 1989; 10: 959-964
20. Vaughn DJ, Jarvik JG, Hackney D, Peters S, Stadtmauer EA. High-dose cytarabine neurotoxicity: MR findings during the acute phase. AJNR Am J Neuroradiol 1993; 14:1014-1016
21. Valk PE, Dillon WP. Radiation injury of the brain. AJNR Am J Neuroradiol 1991; 12:45-62
22. Sullivan KM, Mori M, Sanders J. Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant 1992; 10(suppl 2): 127-134
23. Nierneyer CM, Hitchcock-Bryan S, Sallan SE. Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia. Semin Oncol 1985; 12:122-130
24. Ramsay NKC, Coccia PF, Krivit W, Nesbit M, Edson JR. The effect of L-asparaginase on plasma coagulation factors in acute lymphoblastic leukemia. Cancer 1977; 4:1398-1401
25. Tornebohm E, Lockner D, Paul C. A retrospective analysis of bleeding complications in 438 patients with acute leukaemia during the years 1972-1991. Eur J Haematol 1993; 50:160-167
26. Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost 1992; 18:353-371
27. Creutzig U, Ritter J, Budde M, et al. Early death due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Cancer 1987; 60:3071-3079
28. Collins RC, Al-Mondhiry H, Chernik NL, et al. Neurologic manifestations of intravascular coagulation in patients with cancer: a clinicopathologic analysis of 12 cases. Neurology 1975; 25:795-806
29. Kantarjian HM, Keating MJ, Walters RS, et al. Acute promyelocytic leukemia. Am J Med 1986; 80:789-797
30. Tallman MS, Kwaan HC. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood 1992; 79: 543-553
31. Kubo M, Azuma E, Arai S, Komada Y, et al. Transient encephalopathy following a single exposure of high-dose methotrexate in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1992; 9:157-165
32. Bodey GP. Infection in cancer patients: a continuing association. Am J Med 1986; 81(suppl 1A):11-26
33. Salonen J, Nikoskelainen J. Lethal infections in patients with hematological malignancies. Eur J Haematol 1993;51:102-108
34. Andersen D, Matick H, Naheedy MH, Stein K. Rhinocerebral mucormycosis with CT scan findings: a case report. Comput Radiol 1984; 8:113-117
35. Gamba JL, Woodruff WW, Djang WT, Yeates AE. Craniofacial mucormycosis: assessment with CT. Radiology 1986; 160:207-212
36. Fellows DW, King VD, Conturo T, et al. In vitro evaluation of MR hypointensity in aspergillus colonies. AJNR Am J Neuroradiol 1994 15:1139-1141
37. Sze G, Gadolinium-DTPA in spinal disease. Radiol Clin North Am 1988; 26:1009-1024
38. Bazan C III, Jackson C, Jinkins JR, Barohn RJ. Gadolinium-enhanced MRI in a case of cytomegalovirus polyradiculopathy. Neurology 1991; 41:1522-1523
39. Morgan GW, Barohn RJ, Bazan C III, King RB, Klucznick RP. Nerve root enhancement with MRI in inflammatory demyelinating polyradiculoneuropathy. Neurology 1993; 43:618-620
40. Georgy BA, Chong B, Chamberlain M, Hesselink JR, Cheung G. MR of the spine in Guillain-Barré syndrome. AJNR Am J Neuroradiol 1994; 15:300-301
41. David PC, Friedman NC, Fry SM, et al. Leptomeningeal metastasis: MR imaging. Radiology 1987; 163:449-454.
42. Mathews VP, Kuharik MA, Edwards MK, et al. Gd-DTPA enhanced MR imaging of experimental bacterial meningitis: evaluation and comparison with CT. AJNR Am J Neuroradiol 1988; 9:1045-1050
43. Pinkel D. Patterns of failure in acute lymphocytic leukemia. Cancer Treat Sympt 1983; 2:259-266
44. Price RA, Birdwell DA. The central nervous system in childhood leukemia. III: mineralizing microangiopathy and dystrophic calcification. Cancer 1978; 42:717-728
45. Biti GP, Magrini SM, Villari N, et al. Brain damage after treatment for acute lymphoblastic leukemia: a report on 34 patients with special regard for MRI findings. Acta Oncol 1989; 28:253-256
46. Price RA, Jamieson PA. The central nervous system in childhood leukemia. II: subacute leukoencephalopathy. Cancer 1975; 35: 306-318
47. Henkelman RM, Watts JF, Kucharczyk W. High signal intensity in MR imaging of calcified brain tissue. Radiology 1991; 179:199-206
48. Mike V, Meadows AT, D'Angio GD. Incidence of second malignant neoplasms in children: results of an international study. Lancet 1982;2:1326-1331
49. Malone M, Lumley H, Erodohazi M. Astrocytoma as a second malignancy in patients with acute lymphoblastic leukemia. Cancer 1986; 57:1979-1985
50. Modan B, Mar H, Braidtz D, et al. Radiation-induced head and neck tumors. Lancet 1974; 1:277-279
51. Gilman PA, Miller RW. Cancer after acute lymphoblastic leukemia. Am J Dis Child 1981; 135:311-312
52. Zarrabi MH, Rosner F, Grunwald HW. Second neoplasms in acute lymphoblastic leukemia. Cancer 1983; 52:1712-1719
53. Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 784-789
54. Zutter MM, Martin PJ, Sale GE, et al. Epstein-Barré virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520-529
55. Patton DF, Wilkowski CW, Hanson CA. Epstein-Barr virus determined clonality in posttransplant lymphoproliferative disease. Transplantation 1990; 49:1080-1084
56. Leonard KJ. MR appearance of intracranial chloromas. AJNR Am J Neuromdiol 1989; 10(suppl):67-68
57. Petursson SR, Boggs DR. Spinal cord involvement in leukemia: a review of the literature and a case of Ph' + acute myeloid leukemia presenting with a conus medullaris syndrome. Cancer 1981; 47:346-350